Last Price$59.76.8%
Market Cap$3,532.4M
99.6%
Industry median - 82.6%
5Y Historical average - 73.1%
64.3%
Industry median - (165.5%)
5Y Historical average - (1,309.1%)
42.1%
Industry median - (175.6%)
5Y Historical average - (974.3%)
66.4%
Industry median - 86.2%
5Y Historical average - 87.2%
PTGX Profitability Rating
PTGX Profitability rating
9.1
PTGX Profitability rating performance
PTGX Profitability Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with PTGX Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$3,532.4M | 9.1 | 99.6% | 58.2% | 58.7% | 63.3% | 42.1% | 66.4% | |
$124.8B | 6.8 | 86.1% | (2.2%) | 4.4% | (4.9%) | (7.2%) | 147.6% | |
$77.0B | 8.1 | 84.5% | 28.3% | 33.9% | 31.1% | 25.3% | 81.5% | |
$34.4B | 5.9 | 86.8% | (17.1%) | (2.1%) | (4.5%) | (9.4%) | 103.2% | |
$30.7B | 5.3 | 85.6% | (7.9%) | (8.6%) | (12.4%) | (1.9%) | 15.3% | |
$24.0B | 6.3 | 80.3% | (47.8%) | (13.2%) | (24.2%) | (8.4%) | 33.9% | |
$14.5B | 8.4 | 73.9% | 57.1% | 81.0% | 37.9% | 122.3% | 208.1% | |
$13.8B | 9.1 | 89.2% | 47.9% | 55.9% | 41.5% | 37.6% | 90.4% | |
$13.4B | 8.8 | 78.6% | 16.2% | 22.8% | 15.0% | 16.7% | 111.4% | |
$13.3B | 5.7 | N/A | N/A | N/A | N/A | N/A | 64.2% | |
$1,846.9M | 5.8 | 83.7% | (26.3%) | (22.0%) | (95.0%) | (31.4%) | 121.0% |
FAQ
What is the Protagonist Therapeutics, Inc. (PTGX) gross profit margin?
The Protagonist Therapeutics, Inc. (PTGX) gross profit margin is 99.6%, compared to the industry median of 82.6% and the 5-year historical average of 73.1%.
What is the Protagonist Therapeutics, Inc. (PTGX) operating income margin?
The Protagonist Therapeutics, Inc. (PTGX) operating income margin is 64.3%, compared to the industry median of (165.5%)) and the 5-year historical average of (1,309.1%).
What is the Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow (FCF) margin?
The Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow margin is 42.1%, compared to the industry median of (175.6%) and the 5-year historical average of (974.3%).
What is the Protagonist Therapeutics, Inc. (PTGX) earnings quality?
The Protagonist Therapeutics, Inc. (PTGX) earnings quality is 66.4%, compared to the industry median of 86.2% and the 5-year historical average of 87.2%.